Seagen, A Wholly Owned Subsidiary Of Pfizer

This study tested whether combining two existing cancer drugs, brentuximab vedotin and pembrolizumab, could help treat several types of advanced cancer that had spread to other parts of the body. It involved 161 people with metastatic melanoma, non-small cell lung cancer, or head…

This study tested whether adding the drug brentuximab vedotin to standard chemotherapy (CHP) works for people newly diagnosed with certain aggressive types of peripheral T-cell lymphoma (PTCL) who have low levels of a specific protein called CD30. The trial involved 82 participan…

This study tested a combination of two targeted drugs, tucatinib and trastuzumab deruxtecan, for people with advanced HER2-positive breast cancer that had spread or could not be removed by surgery. The main goal was to see how well the combination worked to shrink tumors and cont…

This study tested the safety and how the body processes an experimental drug called SGN-B6A in Chinese patients with advanced solid tumors. It involved a small group of 6 participants who had cancers like lung, head and neck, or stomach cancer that had stopped responding to stand…

This large, completed Phase 3 trial tested whether a newer drug called tisotumab vedotin works better than standard chemotherapy for women with cervical cancer that has returned or spread after initial treatment. The study involved 502 participants who were randomly assigned to r…